DE3685060D1 - Verwendung von kojic-saeure oder ihres beta-cyclodextrin-einschlusskomplexes zur praevention von elastosis. - Google Patents

Verwendung von kojic-saeure oder ihres beta-cyclodextrin-einschlusskomplexes zur praevention von elastosis.

Info

Publication number
DE3685060D1
DE3685060D1 DE8686108952T DE3685060T DE3685060D1 DE 3685060 D1 DE3685060 D1 DE 3685060D1 DE 8686108952 T DE8686108952 T DE 8686108952T DE 3685060 T DE3685060 T DE 3685060T DE 3685060 D1 DE3685060 D1 DE 3685060D1
Authority
DE
Germany
Prior art keywords
kojic acid
elastosis
preventing
drugs
beta cyclodextrin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686108952T
Other languages
German (de)
English (en)
Inventor
Shinkichi Hatae
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sansho Pharmaceutical Co Ltd
Original Assignee
Sansho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sansho Pharmaceutical Co Ltd filed Critical Sansho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE3685060D1 publication Critical patent/DE3685060D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Electroluminescent Light Sources (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrane Compounds (AREA)
DE8686108952T 1985-07-02 1986-07-01 Verwendung von kojic-saeure oder ihres beta-cyclodextrin-einschlusskomplexes zur praevention von elastosis. Expired - Lifetime DE3685060D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60146029A JPH0613448B2 (ja) 1985-07-02 1985-07-02 皮膚弾力線維症予防剤

Publications (1)

Publication Number Publication Date
DE3685060D1 true DE3685060D1 (de) 1992-06-04

Family

ID=15398494

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686108952T Expired - Lifetime DE3685060D1 (de) 1985-07-02 1986-07-01 Verwendung von kojic-saeure oder ihres beta-cyclodextrin-einschlusskomplexes zur praevention von elastosis.

Country Status (17)

Country Link
US (1) US4891361A (OSRAM)
EP (1) EP0207499B1 (OSRAM)
JP (1) JPH0613448B2 (OSRAM)
KR (1) KR890004556B1 (OSRAM)
AT (1) ATE75396T1 (OSRAM)
AU (1) AU591680B2 (OSRAM)
CA (1) CA1282332C (OSRAM)
DE (1) DE3685060D1 (OSRAM)
DK (1) DK166429B1 (OSRAM)
FI (1) FI862806A0 (OSRAM)
GR (1) GR861671B (OSRAM)
HK (1) HK51594A (OSRAM)
IE (1) IE59082B1 (OSRAM)
IN (1) IN165985B (OSRAM)
PH (1) PH22349A (OSRAM)
PT (1) PT82889B (OSRAM)
ZA (1) ZA864166B (OSRAM)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2809429B2 (ja) * 1989-05-26 1998-10-08 湧永製薬株式会社 制ガン剤ならびに制ガン剤として有用な新規複素環化合物またはそれらの塩
JPH04298437A (ja) * 1991-03-26 1992-10-22 Fuji Photo Film Co Ltd 画像形成装置
US5296472A (en) * 1991-12-05 1994-03-22 Vyrex Corporation Methods for delipidation of skin and cerumen removal
JP3566739B2 (ja) * 1993-09-30 2004-09-15 三省製薬株式会社 皮膚外用剤の安定化方法
US5874463A (en) * 1994-10-24 1999-02-23 Ancira; Margaret Hydroxy-kojic acid skin peel
US6596263B1 (en) * 1995-07-14 2003-07-22 Stc English Ideas, Inc. Cyclodextrin compositions
GB2307176A (en) * 1995-11-15 1997-05-21 Todd Selwyn Everest Anti-inflammatory clathrating agents for topical use
KR100471372B1 (ko) * 2001-12-04 2005-03-08 주식회사 태평양 피부 탄력 향상용 화장료 조성물
US20040126339A1 (en) * 2002-12-31 2004-07-01 Roszell James A. Sunscreen composition and methods for manufacturing and using a sunscreen composition
US20080070982A1 (en) * 2006-09-15 2008-03-20 Graham Timmins System and methods of melanoma prevention

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS533538A (en) * 1976-06-28 1978-01-13 Sansho Seiyaku Kk Skin bleach cosmetics
JPS55157509A (en) * 1979-05-24 1980-12-08 Sansho Seiyaku Kk Ultraviolet ray intercepting agent safe to skin
JPS61109705A (ja) * 1984-11-01 1986-05-28 Sansho Seiyaku Kk 色白化粧料

Also Published As

Publication number Publication date
PH22349A (en) 1988-08-12
GR861671B (en) 1986-10-30
HK51594A (en) 1994-05-27
DK313786A (da) 1987-01-03
JPH0613448B2 (ja) 1994-02-23
DK166429B1 (da) 1993-05-24
EP0207499A2 (en) 1987-01-07
IE861481L (en) 1987-01-02
IE59082B1 (en) 1994-01-12
KR870000931A (ko) 1987-03-10
IN165985B (OSRAM) 1990-02-17
AU5889786A (en) 1987-01-08
ZA864166B (en) 1987-02-25
PT82889A (en) 1986-08-01
EP0207499A3 (en) 1989-04-26
AU591680B2 (en) 1989-12-14
ATE75396T1 (de) 1992-05-15
FI862806A0 (fi) 1986-07-01
CA1282332C (en) 1991-04-02
PT82889B (pt) 1988-05-27
EP0207499B1 (en) 1992-04-29
DK313786D0 (da) 1986-07-01
US4891361A (en) 1990-01-02
JPS625909A (ja) 1987-01-12
KR890004556B1 (ko) 1989-11-15

Similar Documents

Publication Publication Date Title
Slaga et al. Skin tumor-promoting activity of benzoyl peroxide, a widely used free radical-generating compound
DE3582439D1 (de) Mittel zur behandlung von herzerkrankungen.
PT83961A (de) Pyrazolin-derivate ihre herstellung und ihre verwendung als mittel mit insektizider und akarizider wirkung
BE817108A (fr) Compositions d'enzyme presentant une activite et une stabilite ameliorees en solution aqueuse
ATE50926T1 (de) Auf phosphorsaeureester basierende, oberflaechenaktive zusammensetzungen, deren herstellungsverfahren und deren verwendung um wirksame praeparate herzustellen.
FR2544984B1 (fr) Pommade dermique et dermatologique a large spectre d'activite, et son procede de preparation
DE3685060D1 (de) Verwendung von kojic-saeure oder ihres beta-cyclodextrin-einschlusskomplexes zur praevention von elastosis.
ATE20641T1 (de) Pharmazeutisches praeparat zur topischen behandlung von akne.
NO149232C (no) Sporicid, perkarboksylsyreholdig desinfeksjonsmiddel i form av en alkoholisk eller vandig alkoholisk opploesning
ATE258440T1 (de) Verwendung von neutralen gallium chelaten mit 3- hydroxy-4-pyrone verbindungen zur behandlung von krankheiten die verbessert werden können durch die hemmung der hyperproliferation von keratinocyten
ES8705448A1 (es) Procedimiento para la obtencion de derivados de piridina
ATE70453T1 (de) Verwendung von interleukin-1-proteinen gegen arthritis.
IT7921922A0 (it) Procedimento per la determinazione dell'attivita' della colinesterasi e derivati della colina che vengono impiegati nel procedimento.
DE68907386D1 (de) Verwendung von phytinsaeure oder deren salzen zur verhinderung oder behandlung von lebererkrankungen.
DE3650395D1 (de) Gärung zur Gewinnung von d-Milchsäure.
ATE100670T1 (de) Pflanzenfungizide mittel enthaltend als wirstoffe salze der pyrophosphorigen saeure und ihre anwendung.
DE3788473D1 (de) Züchtung von Keratinozyten-Megakolonien und ihre Verwendung für Bestimmungen.
DE3675720D1 (de) Behandlung von material aus lignocellulose.
FI853078A7 (fi) Askorbiinihapon ja askorbiinihappoanalogien platinakomplekseja.
DE3485773D1 (de) Aus kultivierten mesenchymzellen extrahierte makromolekuele zur behandlung von degenerationskrankheiten.
DE68913797D1 (de) Verwendung von Paraaminosalicylsäure zur Stabilisierung der enzymatischen Aktivität von Peroxydase in Lösung, Stabilisierungsmittel und Verwendung von stabiliserter Lösung.
ATE82771T1 (de) Modulation tierischer cellularer reaktionen mittels zubereitungen, die isoxanthopterin-8-(1'beta-aldoglykosidyl)-abk¯mmlinge enthalten.
ATE41007T1 (de) 2-alkanoyloxypropanderivate, ihre herstellung und verwendung.
ES2040229T3 (es) Composiciones farmaceuticas que tienen actividad curativa.
FR2558468B1 (fr) Derives de l'acide b-(4-isocyano-1,2,3,4- diepoxycyclopentyl) acrylique et compositions, notamment pharmaceutiques, les contenant

Legal Events

Date Code Title Description
8364 No opposition during term of opposition